Data Variable Options

Attachment 5B. National HIV Prevention Program Monitoring and Evaluation (NHM&E) Data Variable Options (OMB 0920-0696, Exp. 02/28/2019)

Option 1 is available through December 31, 2018 for health departments funded under PS18-1802. However, additional time may be granted to those health departments unable to transition to Option 2 by that date. Option 1 is required for community based organizations funded under PS15-1502 through the last year of current funding (June 30, 2020) and those funded under PS17-1704 through March 31, 2019.

Option 2 is available to health departments beginning July 1, 2018 and required for all health departments on January 1, 2019. Option 2 will be required for any new CBO NOFO. New Variables will be available following OMB approval.

Variable Number	Variable Name	Option 1: NHM&E Requirements	Option 2: NHM&E Requirements	Status
Agency
A01	Agency Name		
A01a	Agency ID		
A02	Jurisdiction		
A27	CBO Agency Name		
A28	CBO Agency ID		
Site
S01	Site ID		
S04	Site Type		
S08	Site – County		
S09	Site – State		
S10	Site - Zip Code		
S03	Site Name		
CDC
CDC06	CDC Variable 6		
CDC07	CDC Variable 7		
CDC08	CDC Variable 8		
CDC09	CDC Variable 9		
CDC10	CDC Variable 10		
Client
G101	Date Client Demographic Data Collected		
G103	Local Client ID		
G112	Date of Birth - Year		
G114	Ethnicity		
G116	Race		
G120	State/Territory of Residence		
G123	Assigned Sex at Birth		
G124	Current Gender Identity		
G124a	Specify Current Gender Identity	
G132	Client – County		
G134	Client - Zip Code		
G200	Date Client Risk Collected		
G200_1	Client Behavioral Risk Profile	
G204	Previous HIV Test		
G205	Self-Reported HIV Test Result	
G209	Pregnant (Only If Female)		
G210	In Prenatal Care (Only if Pregnant)		
G211_01	Injection Drug Use		
G211_08	Share Drug Injection Equipment	
G212	Additional Client Risk Factors	
G216a	Vaginal or Anal Sex with a Male		
G216b	Vaginal or Anal Sex with a Female		
G216c	Vaginal or Anal Sex with a Transgender Person		
G217a	Vaginal or Anal Sex without a Condom with a Male	
G217b	Vaginal or Anal Sex without a Condom with a Female	
G217c	Vaginal or Anal Sex without a Condom with a Transgender Person	
G218a	Vaginal or Anal Sex with a Male IDU	
G218b	Vaginal or Anal Sex with a Female IDU	
G218c	Vaginal or Anal Sex with a Transgender IDU	
G219a	Vaginal or Anal Sex with HIV-Positive Male	
G219b	Vaginal or Anal Sex with HIV-Positive Female	
G219c	Vaginal or Anal Sex with HIV-Positive Transgender Person	
G220	Vaginal or Anal Sex with MSM (female only)	
G222	Vaginal or Anal Sex without a Condom (PS only)		
G223	Vaginal or Anal Sex with an IDU (PS only)	
G205a	Previous HIV Test Result		
G400	In the past 5 years, has the client/patient had sex with a male?		
G401	In the past 5 years, has the client/patient had sex with a female?		
G402	In the past 5 years, has the client/patient injected drugs that were not prescribed to him/her by a medical care provider?		
G403	In the past 5 years, has the client/patient had sex with a transgender person?			New
Testing 1
H04a	Test Form ID		
H06	Session Date		
H800	Has the client/patient ever heard of PrEP, the medicine taken daily to reduce the risk for getting HIV?		
H802	Has the client/patient used PrEP anytime in the last 12 months?		
H04c	eHARS State Number		
H04d	eHARS City/County Number		
Partner Services
PCR101	Case Number		
PCR103	Case Open Date		
PCR104	Case Close Date		
PCR108	Date of Report	
PCR109	Reported to Surveillance	
PCR200	Date Collected	
PCR202a	Local PS ID	
PCR207	Partner Type		
PCR209	Notification Plan	
PCR104a	Care Status at Case Close Date		
Testing 2
X103	Test Technology	
X104	HIV Test Election	
X104a	HIV Test Election		
X105	Sample Date		
X110	Test Result	
X111	Result Provided		
X115	If Result Not Provided, Why	
X124	Basis of Final Determination		
X125	HIV Test Result, Final Determination		
X126	Preliminary Positive point-of-care rapid test		
X126a	Specimen Collection Date of Preliminary Positive point-of-care rapid test		
X127	Tests for co-infections		
X127a	Syphilis Test		
X127b	Gonorrhea		
X127c	Chlamydial infection		
X127d	Hepatitis C		
X135	Worker ID		
X136	In Surveillance System or Records	
X137	Program Announcement or Program Strategy		
X137-1	Specify Program Announcement/Strategy	
X138	Client HIV Status		
X150	Has the client/patient ever had a positive HIV test?		
X150a	If yes, date of first positive HIV test		
X224	Stage of infection		
X302	Attempt to Locate Outcome		
X303	Reason for Unsuccessful Attempt		
X303a	Specify Reason for Unsuccessful Attempt	
X306	Enrollment Status		
X502	Time Period for Recall (in months)	
X503	Total number of claimed sex and/or needle-sharing partners within the last 12 months		
X511	Total number of named sex and/or needle sharing partners within the last 12 months (with enough information to locate)		
X511a	Total Number of Named Male Partners	
X511b	Total Number of Named Female Partners	
X511c	Total Number of Named Transgender Partners	
X600	Partner Notifiability		
X601	Actual Notification Method		
X602	Previous HIV Test	
X603	Self-Reported HIV Test Result	
X604	Date of Last HIV Test	
X702	Referral Date	
X702a	Reason Client Not Referred to HIV Medical Care	
X703_01	Referred To HIV Testing	
X703_10	Referred To Medical Care	
X703_14	Referred To Partner Services	
X703_17	Referred To HIV Prevention Services	
X706	Referral Outcome	
X706b	First HIV Medical Care Appointment within 90 Days of HIV Test	
X706c	HIV Medical Care Linkage		
X706d	First HJV Medical Appointment Date		
X712	HIV Test Performed		
X712a	Coinfection Screen (Partner Services)		
X712b	Co-infection Result (Partner Services)		
X713	HIV Test Result	
X714a	HIV Test Results Provided		
X724	Client Received Prevention Services	
X725	Partner Service Interview	
X725a	Was the PS Interview within 30 Days of Receiving a Positive HIV Test Result	
X725b	Care Status at Time of the PS Interview		
X730a	Housing status in past 12 months - revised		
X731	PrEP Status		
X731a	Partner referred to PrEP Provider (Partner Services)		
X740	Seen a Medical Care Provider in past 6 months		
X741	Attend HIV medical care appointment		
X741a	Appointment Date		
X742	Individualized behavioral risk-reduction counseling		
X743	Information provided for partner services		
X744	Interviewed for partner services		
X744a	Date of partner services interview		
X745	Screened for perinatal HIV service coordination needs		
X746	Perinatal HIV service coordination needs identified		
X747	Referred for HIV perinatal service coordination		
X748	Screened for PrEP eligibility		
X749	Eligible for PrEP referral		
X750	Referred to a PrEP Provider		
X751	Assistance with linkage to a PrEP provider		
X752a	Navigation services for linkage to HIV medical care – screened for need		
X752b	Navigation services for linkage to HIV medical care – need identified		
X752c	Navigation services for linkage to HIV medical care – provided or referred for service		
X752e	Linkage services to HIV medical care – screened for need		
X752f	Linkage services to HIV medical care – need identified		
X752g	Linkage services to HIV medical care – provided or referred for service		
X753a	Health benefits navigation and enrollment – screened for need		
X753b	Health benefits navigation and enrollment – need identified		
X753c	Health benefits navigation and enrollment – provided or referred to service		
X754a	Medication adherence support – screened for need		
X754b	Medication adherence support – need identified		
X754c	Medication adherence support – provided or referred to service		
X755a	Evidence-based risk reduction intervention – screened for need		
X755b	Evidence-based risk reduction intervention – need identified		
X755c	Evidence-based risk reduction intervention – provided or referred to service		
X756a	Behavioral health services – screened for need		
X756b	Behavioral health services – need identified		
X756c	Behavioral health services – provided or referred to service		
X758a	Social services – screened for need		
X758b	Social services – need identified		
X758c	Social services – provided or referred to service		
Aggregate
ME201a	Category A total PS18-1801-funded aggregate test events		
ME201b	Category A total reimbursed aggregate test events		
ME202a	Category A PS18-1801-funded aggregate newly diagnosed HIV-positive test events		
ME202b	Category A reimbursed aggregate newly diagnosed HIV-positive testing events		
CBO
CBOCL003	Client Record Number		
CBOTEST001	Target Population(s)		
CBOTEST002	High-Risk Client		
CBOTEST003	HIV Medical Care at the time of this positive test		
CBOTEST004	Navigation and prevention and essential support services, HIV Testing		
CBOTEST004SP	Other recommended support services, HIV testing		
CBOTEST005	Date client attended first medical care appointment		
Data Upload
Z03c	Schema Version Number		
Z06	Data Type in File		
Budget	Health Department PS18-1802 Only
BASTRAT10a1P	Percent Allocated - Monitoring and Evaluation - Prevention			New
BASTRAT10a1S	Percent Allocated - Monitoring and Evaluation - Surveillance			New
BASTRAT11a1P	Percent Allocated - Capacity Building and TA - Prevention			New
BASTRAT11a1S	Percent Allocated - Capacity Building and TA - Surveillance			New
BASTRAT11a2P	Percent Allocated - Geocoding - Prevention			New
BASTRAT11a2S	Percent Allocated - Geocoding - Surveillance			New
BASTRAT1a1S	Percent Allocated – Data Activities - Surveillance			New
BASTRAT1a2P	Percent Allocated – Data Activities - Prevention			New
BASTRAT2a1P	Percent allocated - Routine HIV testing, Healthcare -Prevention			New
BASTRAT2a2P	Percent allocated - Targeted HIV testing, non-Healthcare - Prevention			New
BASTRAT2a3P	Percent allocated - HIV Partner Services - Prevention			New
BASTRAT2a4P	Percent allocated - D2C - Prevention			New
BASTRAT2a4S	Percent expended - D2C - Surveillance			New
BASTRAT3a1P	Percent Allocated - HIV Transmission Clusters and Outbreaks - Prevention			New
BASTRAT3a1S	Percent Allocated - HIV Transmission Clusters and Outbreaks - Surveillance			New
BASTRAT4a1P	Percent Allocated - CPP, Continuum of Care - Prevention			New
BASTRAT4a2P	Percent Allocated - CPP, Risk Reduction Interventions - Prevention			New
BASTRAT4a3P	Percent Allocated - Other CPP - Prevention			New
BASTRAT5a1P	Percent Allocated - Prevention with HIV-negative persons - Prevention			New
BASTRAT5a2P	Percent Allocated - PrEP Access and Support - Prevention			New
BASTRAT5a3P	Percent Allocated - PEP Access and Support - Prevention			New
BASTRAT6a1P	Percent Allocated - Perinatal HIV Exposure Reporting - Prevention			New
BASTRAT6a1S	Percent Allocated - Perinatal HIV Exposure Reporting - Surveillance			New
BASTRAT6a2P	Percent Allocated - Perinatal HIV Surveillance Coordination - Prevention			New
BASTRAT6a2S	Percent Allocated - Perinatal HIV Surveillance Coordination - Surveillance			New
BASTRAT7a1P	Percent Allocated - Community-level Prevention Activities - Prevention			New
BASTRAT7a2P	Percent Allocated - SSP - Prevention			New
BASTRAT7a3P	Percent Allocated - Condom Distribution - Prevention			New
BASTRAT8a1P	Percent Allocated - HIV Planning - Prevention			New
BASTRAT8a1S	Percent Allocated - HIV Planning - Surveillance			New
BASTRAT9a1P	Percent Allocated - Health Information Infrastructure - Prevention			New
BASTRAT9a1S	Percent Allocated - Health Information Infrastructure -Surveillance			New
BASTRAT9a2P	Percent Allocated - Data Security and Confidentiality - Prevention			New
BASTRAT9a2S	Percent Allocated - Data Security and Confidentiality - Surveillance			New
BASTRAT9a3P	Percent Allocated - Policies and Protocols - Prevention			New
BASTRAT9a3S	Percent Allocated - Policies and Protocols - Surveillance			New
BESTRAT10a1P	Percent Expended - Monitoring and Evaluation - Prevention			New
BESTRAT10a1S	Percent Expended - Monitoring and Evaluation - Surveillance			New
BESTRAT11a1P	Percent Expended - Capacity Building and TA - Prevention			New
BESTRAT11a1S	Percent Expended - Capacity Building and TA - Surveillance			New
BESTRAT11a2P	Percent Expended - Geocoding - Prevention			New
BESTRAT11a2S	Percent Expended - Geocoding - Surveillance			New
BESTRAT1a1S	Percent Expended – Data Activities - Surveillance			New
BESTRAT1a2P	Percent expended - NHME			New
BESTRAT2a1P	Percent expended - Routine HIV testing, Healthcare - Prevention			New
BESTRAT2a2P	Percent expended - Targeted HIV testing, non-Healthcare - Prevention			New
BESTRAT2a3P	Percent expended - HIV Partner Services - Prevention			New
BESTRAT2a4P	Percent expended - D2C - Prevention			New
BESTRAT2a4S	Percent expended - D2C - Surveillance			New
BESTRAT3a1P	Percent Expended - HIV Transmission Clusters and Outbreaks - Prevention			New
BESTRAT3a1S	Percent Expended - HIV Transmission Clusters and Outbreaks - Surveillance			New
BESTRAT4a1P	Percent Expended - CPP, Continuum of Care - Prevention			New
BESTRAT4a2P	Percent Expended - CPP, Risk Reduction Interventions - Prevention			New
BESTRAT4a3P	Percent Expended - Other CPP - Prevention			New
BESTRAT5a1P	Percent Expended - Prevention with HIV-negative persons - Prevention			New
BESTRAT5a2P	Percent Expended - PrEP Access and Support - Prevention			New
BESTRAT5a3P	Percent Expended - PEP Access and Support - Prevention			New
BESTRAT6a1P	Percent Expended - Perinatal HIV Exposure Reporting - Prevention			New
BESTRAT6a1S	Percent Expended - Perinatal HIV Exposure Reporting - Surveillance			New
BESTRAT6a2P	Percent Expended - Perinatal HIV Surveillance Coordination - Prevention			New
BESTRAT6a2S	Percent Expended - Perinatal HIV Surveillance Coordination - Surveillance			New
BESTRAT7a1P	Percent Expended - Community-level Prevention Activities - Prevention			New
BESTRAT7a2P	Percent Expended - SSP - Prevention			New
BESTRAT7a3P	Percent Expended - Condom Distribution - Prevention			New
BESTRAT8a1P	Percent Expended - HIV Planning - Prevention			New
BESTRAT8a1S	Percent Expended - HIV Planning - Surveillance			New
BESTRAT9a1P	Percent Expended - Health Information Infrastructure - Prevention			New
BESTRAT9a1S	Percent Expended - Health Information Infrastructure - Surveillance			New
BESTRAT9a2P	Percent Expended - Data Security and Confidentiality - Prevention			New
BESTRAT9a2S	Percent Expended - Data Security and Confidentiality - Surveillance			New
BESTRAT9a3P	Percent Expended - Policies and Protocols - Prevention			New
BESTRAT9a3S	Percent Expended - Policies and Protocols - Surveillance			New
CSTRATEGY1	Comments - Strategy 1			New
CSTRATEGY10	Comments - Strategy 10			New
CSTRATEGY11	Comments - Strategy 11			New
CSTRATEGY2	Comments - Strategy 2			New
CSTRATEGY3	Comments - Strategy 3			New
CSTRATEGY4	Comments - Strategy 4			New
CSTRATEGY5	Comments - Strategy 5			New
CSTRATEGY6	Comments - Strategy 6			New
CSTRATEGY7	Comments - Strategy 7			New
CSTRATEGY8	Comments - Strategy 8			New
CSTRATEGY9	Comments - Strategy 9			New

10